RPL17 and autoimmune disease: These findings are in line with previous reports in Ldlr−/−Pd1−/−[10] and Ldlr−/−Pdl1/Pdl2−/−[11] mice, and consistent with the important role of PD-1 signaling in taming T cell activation in inflammatory and autoimmune diseases [12].